Congress in Spain were a major feature of research news last week, including those from Pfizer on it ponsegromab in cancer ...

Everything we covered on WTR over the past seven days, and all you need to know from the world of trademarks to set yourself up for the start of another busy week.

Niger has become the latest West African country to roll out malaria vaccines to try to stifle the potentially deadly disease ...

IDEAYA Biosciences is a promising biotech company targeting genetic vulnerabilities in cancer cells with synthetic lethality.

Shields has been vocal about women's wellness and now backs an initiative for women to be aware of an infection that's ...

A large development site in Stevenage town centre, formerly home to BHS, has been put on the market for £9 million.

Neuberg Diagnostics has introduced 'Geniee', a mobile platform for personalized genomics, offering genetic testing and tailored medicine. This initiative aims to provide insights into how genes affect ...

Bank of America Securities analyst Graham Parry maintained a Sell rating on GlaxoSmithKline (GSK – Research Report) yesterday and set a ...

ABUJA (Reuters) - Coca-Cola plans to invest $1 billion in its Nigeria operations over the next five years, the country's ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

The recent trial regarding the discontinued heartburn drug Zantac, which allegedly causes cancer, ended in a hung jury. The ...

The latest trial over claims that the discontinued heartburn drug Zantac causes cancer ended with a hung jury on Wednesday, ...